Mather Group »

Contineum Therapeutics shares owned by Mather Group

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Mather Group from 13F filings

Historical chart of Mather Group investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Mather Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Mather Group

Quarter filed Position value Share count Share price at filing
2026-09-30 $2.8k 211 13.42

More positions owned by Mather Group

Vanguard Index Fds Mrngstr Grwt Etf (VUG)
Vanguard Index Fds Mrngstr Val Etf (VTV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Spdr Series Trust St Inter Etf (SPTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Dfa Invt Dimensions Group In U.s. Sml Cp Val (DFSV)
Ishares Tr Tips Bd Etf (TIP)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Index Fds MRNGSTR SM CP GR (VBK)
Dimensional Etf Trust Intl Small Cap V (DISV)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)

View all positions for Mather Group

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management
Geode Capital Management

View all funds holding Contineum Therapeutics